 |
Ritonavir powder for oral suspension |
|---|---|
| Trade Name | Norvir Powder For Oral Suspension |
| Orphan Indication | Use with other antiretroviral agents for the treatment of pediatric HIV-1 infection |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-11 00:00:00 |
| Sponsor | AbbVie Inc.;Regulatory Affairs, 1 Waukegan Road;North Chicago, Illinois, 60044 |
